FDA product code QNL: Medium-Term Adjunctive Predictive Cardiovascular Indicator

QNL is the FDA product code for medium-term adjunctive predictive cardiovascular indicator. It is a Class II device, regulated under 21 CFR 870.2210 and reviewed by the Cardiovascular panel. FDA has cleared 6 510(k) submissions under QNL, 5 in the last five years, from 5 different applicants. The average 510(k) review took 208 days (median 235); 223 days on average over the last three years.

Definition

The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.

Classification

FieldValue
Device nameMedium-Term Adjunctive Predictive Cardiovascular Indicator
Device classClass II
Regulation21 CFR 870.2210
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)

510(k) clearances per year for QNL

YearClearancesAvg. review days
20211297
20232158
20242187
20261259

Compare with all 510(k) review times · Search every QNL clearance

Top QNL applicants

ApplicantClearancesLatest
Clew Medical , Ltd.22024-01-13
Epic Systems Corporation12026-09-18
Agilemd, Inc.12024-06-21
Implicity, Inc.12023-10-25
Edwards Lifesciences, LLC12023-07-26

Most recent QNL clearances

510(k)ApplicantDeviceDecision dateReview days
K260008Epic Systems CorporationDeterioration Index Version 22026-09-18259
K233253Agilemd, Inc.eCARTv5 Clinical Deterioration Suite (“eCART”)2024-06-21267
K233216Clew Medical , Ltd.CLEWICU System2024-01-13107
K230842Implicity, Inc.SignalHF (IM008)2023-10-25211
K231038Edwards Lifesciences, LLCGlobal Hypoperfusion Index (GHI) Algorithm2023-07-26105

Recalls for QNL devices

FDA recall records list no recalls for product code QNL.

Frequently asked questions

What is FDA product code QNL?

QNL is the FDA product code for medium-term adjunctive predictive cardiovascular indicator. It is a Class II device, regulated under 21 CFR 870.2210 and reviewed by the Cardiovascular panel.

What device class is QNL?

Class II, regulation 21 CFR 870.2210. Typical premarket route: 510(k).

How long does a 510(k) take for product code QNL?

Across 6 cleared submissions the average was 208 days from receipt to decision (median 235).

Which companies have the most QNL clearances?

Clew Medical , Ltd. (2); Epic Systems Corporation (1); Agilemd, Inc. (1); Implicity, Inc. (1); Edwards Lifesciences, LLC (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times